Deficits in substance P mRNA levels in the CeA are inversely associated with alcohol-motivated responding.
In the present study, in vitro and in vivo studies were conducted to determine the relationship between innate substance P (SP) levels and alcohol-motivated behavior in alcohol-preferring (P) and nonpreferring (NP) rat lines. In Experiment 1, in situ hybridization and quantitative autoradiography were used to detect and measure SP mRNA levels in discrete brain loci of the P and NP rats. The results indicated significantly lower SP mRNA levels in the central nucleus of the amygdala (CeA) of P compared with those of NP rats. Experiment 2 evaluated the effects of SP, microinfused into the CeA, on alcohol (10%, v/v) and sucrose (2%, w/v) motivated responding in the P rat. The results revealed that, when infused into the CeA (1-8 microg), SP reduced alcohol responding by 48-85% of control levels, with no effects on sucrose responding. Neuroanatomical control infusions (1-8 microg) into the caudate putamen (CPu) also failed to significantly alter alcohol- or sucrose-motivated behaviors. Given the selective reductions on alcohol (compared to sucrose) responding by direct intracranial infusion of SP, the data suggest that deficits in SP signaling within the CeA (an anxiety regulating locus) are inversely associated with alcohol-motivated behaviors. Activation of SP receptors in the CeA may reduce anxiety-like behavior in the P rat and contribute to reductions on alcohol responding. The SP system may be a suitable target for the development of drugs to reduce alcohol-drinking behavior in humans.
Yang
Andrew Rong Song Tzeng
AR
Division of Alcohol and Drug Abuse, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
Yi
Heon Soo
HS
Mamczarz
Jacek
J
June
Harry L
HL
Hwang
Bang H
BH
June
Harry L
HL
D000437:Alcoholism / Q000235:genetics / Q000503:physiopathology; D000679:Amygdala / Q000378:metabolism*; D000818:Animals; D001007:Anxiety / Q000503:physiopathology; D001345:Autoradiography; D016739:Behavior, Addictive / Q000235:genetics / Q000503:physiopathology; D002492:Central Nervous System Depressants / Q000494:pharmacology*; D000431:Ethanol / Q000494:pharmacology*; D017403:In Situ Hybridization; D008297:Male; D009042:Motivation; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D013373:Substance P / Q000378:metabolism*
D002492:Central Nervous System Depressants; D012333:RNA, Messenger; D013373:Substance P; D000431:Ethanol